Business
Director Share Purchases
Director Share Purchases.
About this update from Advanced Medical Solutions Group Plc
[{"type":"text","content":"\n RNS Number : 6415T Advanced Medical Solutions Grp PLC 10 June 2009 \n \n\n\n\n\nFor immediate release\n\n\n10 June 2009\n\n\n\n\n\n\nAdvanced Medical Solutions Group PLC \n('AMS' or the 'Company')\n\nDirector Share Purchases\n\nAdvanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, announces that the following Directors purchased ordinary shares of 5 pence each ('Ordinary Shares') on 9 June 2009. \n\n\n\n\n\n\nDirector\n\n\nShares purchased\n\n\nPurchase price (p)\n\n\nResultant holding\n\n\n% of issued share capital\n\n\n\n\nDon Evans, Chief Executive Officer\n\n\n20,000\n\n\n25.5\n\n\n869,591\n\n\n0.60\n\n\n\n\nMary Tavener, Finance Director\n\n\n25,000\n\n\n25.5\n\n\n246,130\n\n\n0.17\n\n\n\n\nSteve Harris, Non-executive Director\n\n\n79,270\n\n\n25.0\n\n\n202,127\n\n\n0.14\n\n\n\n\n\n\nFor further information, please contact:\n\n\n\n\n\nAdvanced Medical Solutions Group plc\nDon Evans, Chief Executive Officer\nMary Tavener, Finance Director\nwww.admedsol.com\n\n\n\nTel: +44 (0) 16 0654 5508\n\n\n\n\nBuchanan Communications\nMark Court \nStasa Filiplic\n\n\n\nTel: +44 (0) 20 7466 5000\n\n\n\n\nInvestec Bank plc\nRichard Jones\nTim Pratelli\n\n\n\nTel: +44 (0) 20 7597 5970 \n\n\n\n\n\nNotes to Editors:\n\nAdvanced Medical Solutions is a leading company in the development and manufacture of products for the $15 billion global woundcare market.\n\nFounded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative products for advanced woundcare and wound closure. \n\nThe advanced woundcare products are based on the moist wound healing principle. AMS uses its inhouse technology to provide a vertically integrated 'one stop shop' for all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery for distribution and sale into customer markets.\n\nThe acquisition of a 49.4% stake in Corpura BV in May 2008 strengthened AMS's position in hydrophilic polyurethane foam - the largest and fastest growing segment of the advanced woundcare market.\n\nAMS' technology in cyanoacrylate based tissue adhesives is used for the closure of small cuts and trauma wounds through to large surgi...